Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JTS2400017	favezelimab帕博利珠单抗注射液	favezelimab;pembrolizumab	Injection	Biological Products	Disposable Import Drug Application	2024-03-12					view
JXSB2101058	帕博利珠单抗注射液	pembrolizumab	Injection	Biological Products(2.2)	Supplementary Application	2021-09-13					view
JYSB1900252	帕博利珠单抗注射液	pembrolizumab	Injection	Biological Products	Supplementary Application	2019-09-13	Merck Sharp & Dohme Corp.	Merck Sharp & Dohme Corp	Certificate Issued	2019-11-22	view
JYSB2300201	帕博利珠单抗注射液	pembrolizumab	Injection	Biological Products(3.1)	Supplementary Application	2023-12-01					view
JXSL1800030	帕博利珠单抗注射液	pembrolizumab	Injection	Biological Products	Import Drug Application	2018-09-12	默沙东研发（中国）有限公司	MSD R&D (China) Co Ltd	Certificate Issued	2018-10-29	view
JXSS2300011	帕博利珠单抗注射液	pembrolizumab	Injection	Biological Products(3.1)	Import Drug Application	2023-01-18					view
JXSB2100007	帕博利珠单抗注射液	pembrolizumab	Injection	Biological Products(3.1)	Supplementary Application	2021-01-08	默沙东研发（中国）有限公司	MSD R&D (China) Co Ltd	In Review	2022-01-19	view
JXSL2400074	帕博利珠单抗注射液	pembrolizumab	Injection	Biological Products(2.2)	Import Drug Application	2024-04-10					view
JXSS2200010	帕博利珠单抗注射液	pembrolizumab	Injection	Biological Products(3.1)	Import Drug Application	2022-03-08					view
JYSB2000289	帕博利珠单抗注射液	pembrolizumab	Injection	Biological Products	Supplementary Application	2020-06-28			In Review	2020-06-25	view
JXSB2101041	帕博利珠单抗注射液	pembrolizumab	Injection	Biological Products	Supplementary Application	2021-07-28					view
JXSL2000001	帕博利珠单抗注射液	pembrolizumab	Injection	Biological Products	Import Drug Application	2020-01-16	默沙东研发（中国）有限公司	MSD R&D (China) Co Ltd	In Review	2020-01-15	view
JXSL2400059	帕博利珠单抗注射液	pembrolizumab	Injection	Biological Products(2.2)	Import Drug Application	2024-03-12					view
JXSL2101055	帕博利珠单抗注射液	pembrolizumab	Injection	Biological Products(2.2)	Import Drug Application	2021-07-08					view
JYSB1800259	帕博利珠单抗注射液	pembrolizumab	Injection	Biological Products	Supplementary Application	2018-11-28			In Review	2018-11-27	view
JXSB2300062	帕博利珠单抗注射液	pembrolizumab	Injection	Biological Products	Supplementary Application	2023-05-22					view
JXSL2101109	帕博利珠单抗注射液	pembrolizumab	Injection	Biological Products(2.2)	Import Drug Application	2021-09-14					view
JXSB2200056	帕博利珠单抗注射液	pembrolizumab	Injection	Biological Products(2.2)	Supplementary Application	2022-05-07					view
JXSB2000034	帕博利珠单抗注射液	pembrolizumab	Injection	Biological Products(2.2)	Supplementary Application	2020-10-21	默沙东研发（中国）有限公司	MSD R&D (China) Co Ltd	In Review	2020-10-20	view
JXSL2101135	帕博利珠单抗注射液	pembrolizumab	Injection	Biological Products(2.2)	Import Drug Application	2021-11-22					view